W., Bueter M., Theis N., Werling M., Ashrafian H., Lowenstein C., et al
No debe tomar Wegovy si usted o un familiar ha sido diagnosticado con neoplasia endocrina mltiple tipo 2.4 o cncer medular de tiroides
Medical weight loss often leads to better blood pressure, cholesterol, blood sugar control, and improved energy
The free FitOn app offers guided versionstry their Quick Bodyweight Blast for variety
Gastrointestinal side effects are the most common and include: Nausea (reported in 12% to 29% of patients, depending on dose) Diarrhea (occurring in 13% to 23% of patients) Vomiting (affecting 4% to 9% of patients) Constipation (reported in 6% to 11% of patients) Abdominal pain and dyspepsia (affecting 6% to 9% of patients) Decreased appetite (common and often contributes to weight loss) These gastrointestinal symptoms typically occur during dose escalation and often improve with continued use
Biopolymers 22 , 25772637 (1983)